<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>前免疫</title><link/>https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%20%5BNLMID%5D&amp;utm_content = 101111111101 e462414＆utm_medium = rss<description>前免疫：PubMed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%5BNLMID%5D&amp;utm_content=101560960&amp;ff=20250212091005&amp;utm_campaign=journals&amp;utm_source=Chrome&amp;fc=None&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> en</language><lastbuilddate>星期三，2025年2月12日14:10:06 +0000</lastbuilddate><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><ttl> 120</ttl><item><title>来自点头和小鼠的血清和撕裂自身抗体是Sjögren病中局部和全身炎症的潜在诊断指标</title><link/>https://pubmed.ncbi.nlm.nih.gov/39936155/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250212091005&amp;v=2.18.0.post9+e462414<description>结论：与SJD相关的AD的点头和NOT小鼠在眼泪和血清中具有独特的自身抗体谱。与撕裂IgG自身抗体相比，撕裂IgA同种型自身抗体的多样性更大。在LG中观察到的TLS可能是撕裂自身抗体的来源。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月28日； 15：1516330。 doi：10.3389/fimmu.2024.1516330。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：Sjögren病（SJD）是一种自身免疫性疾病，其特征是唾液和泪腺（LG）的淋巴细胞浸润。 LG产生泪液中蛋白质富含水性的水分，并因此可以改变与SJD相关的自身免疫性脂肪腺炎（AD），因此可能会改变泪液自身抗体组成。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：使用免疫荧光评估了来自SJD相关的AD的两个鼠模型，雄性非肥胖糖尿病（NOD）和雄性非肥胖胰岛素抗性（NOR）小鼠的LG中的三级淋巴样结构（TLS）。在三项研究中，使用自动抗体微阵列相对于血清和健康的雄性BALB/C小鼠的泪水，对血清中的IgG和IgA反应性进行了三项研究，对80-120自动抗原的泪液进行了探测。使用LG的SCRNA-Seq（GSE132420）研究了Ig泪液中的Ig来源。数据通过R软件包Limma和Seurat分析。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：从两个SJD模型的LG切片中免疫荧光的分析均显示出TLS。在所有研究中，两种SJD模型中的泪液和血清中只有一种自身抗体显着升高。 Three autoantibodies were significantly elevated in serum but not in tears in both SjD models across all studies.相反，在两种SJD模型中，六个IgG和13个IgA自身抗体（6个共享自动抗原）的眼泪明显升高，但血清却没有升高。 Igha and Ighg2b expressing cells were identified in the plasma cell cluster of NOD.H2b LG. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: NOD and NOR mice with SjD-associated AD have distinct autoantibody profiles in tears and serum. Tear IgA isotype autoantibodies showed a greater diversity than tear IgG autoantibodies.在LG中观察到的TLS可能是撕裂自身抗体的来源。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39936155/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39936155</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810956/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810956</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1516330>10.3389/fimmu.2024.1516330</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39936155</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Shruti Singh Kakan</dc:creator><dc:creator>萨拉·阿卜杜勒米德（Sara Abdelhamid）</dc:creator><dc:creator> yaping ju</dc:creator><dc:creator> J Andrew Mackay</dc:creator><dc:creator>玛丽亚·埃德曼（Maria C Edman）</dc:creator><dc:creator>印度拉曼</dc:creator><dc:creator>郑朱</dc:creator><dc:creator>Prithvi Raj</dc:creator><dc:creator> Sarah F Hamm-Alvarez</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>来自点头和小鼠的血清和撕裂自身抗体是Sjögren病中局部和全身炎症的潜在诊断指标</dc:title><dc:identifier>PMID：39936155</dc:identifier><dc:identifier> PMC：PMC11810956</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1516330</dc:identifier></item><item><title> Single-cell RNA sequencing revealed PPARG promoted osteosarcoma progression: based on osteoclast proliferation</title><link/> https://pubmed.ncbi.nlm.nih.gov/39936154/?utm_source=chrome&amp;utm_medium = rsss＆utm_campaign = Journals&amp;utm_campaign = Journals＆utm_content = 101560960&amp;fc=none&amp;fc=none&amp;ff=2022022022025021022021021021022022021021022021021021022021021022022021021021022022022022022022021022022022022022022022022022022022022022022转<description>结论：这项研究通过SCRNA-SEQ增强了我们对OS和破骨细胞的理解。此外，我们发现PPARG扩大了破骨细胞的激活和增殖，从而导致骨基质的过度吸收和降解，从而为肿瘤细胞增殖和生长创造了有利的环境。通过创新的靶向PPARG，它影响了破骨细胞增殖，从而影响了肿瘤进展。这项工作为...提供了新的见解和方向。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月28日； 15：1506225。 doi：10.3389/fimmu.2024.1506225。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：骨肉瘤（OS）是最常见的原发性恶性骨肿瘤之一，主要起源于间充质组织。它因其高侵入性，高残疾率，高死亡率和预后不良而臭名昭著。在大多数原发性和转移性恶性肿瘤中，骨骼破坏可以促进癌症进展，这与破骨细胞激活以及成骨细胞和破骨细胞之间的不平衡密切相关。大量研究证实，破骨细胞是OS的重要组成部分，在破坏骨骼稳态和促进OS的进展方面发挥了积极作用。因此，我们对单细胞水平的破骨细胞进行了详细研究，旨在找到新的OS治疗靶标，以防止肿瘤进展和局部扩散。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们分析了OS患者和使用的Monocle2，Cytotrace和Slingshot软件的单细胞测序数据，以分析OS进展过程中的伪序轨迹。 CellChat用于揭示细胞之间的通信。增齿用于鉴定破骨细胞中的主动转录因子。最后，我们通过RT-QPCR分析，CCK-8测定，伤口愈合测定，Transwell Assay等进一步证明了结果。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：通过OS中的单细胞测序数据的分析，我们确定了一个高度特定的亚组C2MKI67+破骨细胞。该亚组中的关键信号通路应用程序和前1个转录因子PPARG在破骨细胞增殖和分化中起着至关重要的作用。鉴于破骨细胞在OS进展中的关键作用，我们推测这些信号通路和转录因子可以作为新的治疗靶标出现，从而提供了OS治疗的创新策略。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：这项研究通过SCRNA-SEQ增强了我们对OS和破骨细胞的理解。此外，我们发现PPARG扩大了破骨细胞的激活和增殖，从而导致骨基质的过度吸收和降解，从而为肿瘤细胞增殖和生长创造了有利的环境。通过创新的靶向PPARG，它影响了破骨细胞增殖，从而影响了肿瘤进展。这项工作为OS患者的临床治疗提供了新的见解和方向。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39936154/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39936154</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810940/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810940</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1506225>10.3389/fimmu.2024.1506225</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39936154</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator>雷太阳</dc:creator><dc:creator>金张张</dc:creator><dc:creator>Zhikai Xiahou</dc:creator><dc:creator> Zhenzhen Zhao</dc:creator><dc:creator> Yanchen Liang</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>单细胞RNA测序显示PPARG促进了骨肉瘤进度：基于破骨细胞增殖</dc:title><dc:identifier>PMID：39936154</dc:identifier><dc:identifier> PMC：PMC11810940</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1506225</dc:identifier></item><item><title>病例报告：在Dock8缺乏症中使用Dupilumab的移植和先发制人治疗时期的高龄</title><link/>https://pubmed.ncbi.nlm.nih.gov/39936153/？<description>由于基因编码DOCK8的基因突变，缺乏细胞因子8（DOCK8）缺乏症是一种组合免疫缺陷（CID）。主要的临床现象是肺和皮肤，特应性湿疹的重复感染以及恶性肿瘤的倾向，导致预后不良。典型的发现包括高度升高的IgE和嗜酸性粒细胞。同种异体造血干细胞移植（AllOHSCT）表示为唯一的治疗方法。我们向患者展示... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月28日； 15：1507494。 doi：10.3389/fimmu.2024.1507494。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">由于基因编码DOCK8的基因突变，缺乏细胞因子8（DOCK8）缺乏症是一种组合免疫缺陷（CID）。主要的临床现象是肺和皮肤，特应性湿疹的重复感染以及恶性肿瘤的倾向，导致预后不良。典型的发现包括高度升高的IgE和嗜酸性粒细胞。同种异体造血干细胞移植（AllOHSCT）表示为唯一的治疗方法。我们提出了一名患有晚期疾病的患者，该患者在使用dupilumab和利妥昔单抗的个性化预处理后11岁，导致IgE水平降低并改善了皮肤状况。此外，在对文献的综述中，我们总结了年龄在8岁以上接受AlloHSCT的Dock8缺陷患者中的发病率和结果。在较老的Dock8缺乏的患者中，危及生命的感染，恶性肿瘤和与器官损害的并发症具有挑战性。在较大的研究中，应评估杜皮鲁姆布在Dock8缺乏症中的治疗作用。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39936153/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39936153</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810938/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810938</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1507494>10.3389/fimmu.2024.1507494</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39936153</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator>索菲亚·特朗梅洛（Sophia Trombello）</dc:creator><dc:creator>安德里亚·贾里奇（Andrea Jarisch）</dc:creator><dc:creator>安德烈·威拉斯（Andre Willasch）</dc:creator><dc:creator>伊娃的递减者</dc:creator><dc:creator>朱莉娅·菲卡杜·塞巴尔德（Julia Fekadu-Siebald）</dc:creator><dc:creator>德克·霍尔辛格</dc:creator><dc:creator>罗兰·阿德尔曼（Roland Adelmann）</dc:creator><dc:creator>彼得·巴德</dc:creator><dc:creator>Shahrzad Bakhtiar</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>病例报告：在Dock8缺乏症中使用Dupilumab的移植和先发制人治疗时期的高龄</dc:title><dc:identifier>PMID：39936153</dc:identifier><dc:identifier> PMC：PMC11810938</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1507494</dc:identifier></item><item><title>使用免疫信息和结构方法设计针对钩端螺旋体病的广谱多质亚基疫苗</title><link/>https://pubmed.ncbi.nlm.nih.gov/39936152/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250212091005&amp;v=2.18.0.post9+e462414<description>简介：钩端螺旋体病是由钩端螺旋体引起的，是一种被忽视的人畜共患病，对人类和动物构成了重要的全球健康风险。抗菌素抗性的兴起和现有疫苗的效率低下，凸显了对新的预防策略的迫切需求。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月28日； 15：1503853。 doi：10.3389/fimmu.2024.1503853。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：钩端螺旋体病是由<i>钩端螺旋体</i>引起的，是一种被忽视的人畜共患病，对人类和动物构成了重要的全球健康风险。抗菌素抗性的兴起和现有疫苗的效率低下，凸显了对新的预防策略的迫切需求。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：采用免疫信息方法来设计针对钩端螺旋体病的多质亚基疫苗（MESV）。从五种五个关键的<i>钩端螺旋体</i>蛋白中选择B细胞，细胞毒性T淋巴细胞（CTL）和辅助T淋巴细胞（HTL）表位。这些表位与肝素结合的血凝素（HBHA）佐剂和适当的接头融合在一起，以构建广谱疫苗。评估了疫苗的物理化学特性，包括抗原性，免疫原性，过敏性和保护。对疫苗的3D结构进行了建模，优化和验证。进行了分子对接，分子动力学模拟和MM-GBSA分析，以评估疫苗与Toll样受体的结合相互作用（TLR2和TLR4）。还进行了免疫模拟和<i>计算机克隆中，</i>以评估疫苗的免疫反应和表达潜力。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：MESV表现出高抗原性，免疫原性，非过敏性和跨不同<i>钩端螺旋体</i>菌株的保护。人口覆盖率分析表明，T细胞表位与HLA分子显着相互作用，占全球人口的95.7％。分子对接表现出与TLR2和TLR4的强和稳定结合，结合能分别为-1,357.1 kJ/mol和-1,163.7 kJ/mol。分子动力学模拟和MM-GBSA分析证实了这些相互作用的稳定性，并准确计算了分子间结合的自由能。免疫模拟表明B和T细胞反应强大，并且<i>在硅</i>克隆中表明该疫苗可以在<i>大肠杆菌</i>中成功表达。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">讨论：这些发现表明，MESV是预防钩端螺旋体病的有前途的候选人，提供了强大的免疫反应和广泛的人口覆盖范围。但是，进一步的<i>体内</i>研究对于验证其功效和安全性是必要的。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39936152/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39936152</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11811080/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11811080</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1503853>10.3389/fimmu.2024.1503853</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39936152</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Guneswar Sethi</dc:creator><dc:creator>年轻的Kyu Kim</dc:creator><dc:creator> Su-cheol Han</dc:creator><dc:creator>钟hohwang</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>Designing a broad-spectrum multi-epitope subunit vaccine against leptospirosis using immunoinformatics and structural approaches</dc:title><dc:identifier> PMID：39936152</dc:identifier><dc:identifier> PMC：PMC11811080</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1503853</dc:identifier></item><item><title>重组Sptransformer蛋白与海胆吞噬细胞上的特定位点结合并调节&lt;em>; sptransformer &lt;/em>;基因表达和免疫反应性</title><link/>https://pubmed.ncbi.nlm.nih.gov/39936151/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250212091005&amp;v=2.18.0.post9+e462414<description>结论：这些发现强调了SPTRF蛋白在紫色海胆的先天免疫系统中的多方面和动态功能。它们的功能多样化，可以实现强大的免疫反应，同时还提供了一种独特的调节机制，通过控制响应水平并将其调整为外国威胁水平。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月28日； 15：1496832。 doi：10.3389/fimmu.2024.1496832。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：加利福尼亚紫色海胆， <i>purpuratus purpuratus</i> ，仅依赖于先天免疫系统来生存在其富含病原体的海洋环境中。这种防御的核心是Euchinoders群独有的<i>Sptransformer（SPTRF）</i>基因家族。这些基因最初是根据对免疫挑战的醒目上调来鉴定的。 <i>SPTRF</i>基因家族在结构相似的蛋白质中编码具有广泛序列多样性的蛋白质内部和单个海胆中的序列多样性。重组（R）SPTRF蛋白与多种非自动靶标有特异性相互作用。与惰性珠交联的其他RSPTRF蛋白在细胞结合和增强吞噬作用方面具有不同的功能。但是，RSPTRF蛋白是否与海胆吞噬细胞结合，结合的细胞后果在很大程度上没有探索。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：通过细胞学，流式细胞术，使用细胞内ELISA的结合竞争和基因表达分析研究了RSPTRF蛋白与吞噬细胞的结合和吞噬细胞的反应。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：可溶性RSPTRF蛋白特异性地结合，专门与活的和固定的多边形和小吞噬细胞结合。不同的RSPTRF蛋白似乎结合了共享受体或其他形式的细胞表面结合位点。对结合RSPTRF蛋白的吞噬细胞反应最终导致<i>SPTRF</i>基因家族的调节表达以及其他免疫相关基因。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：这些发现强调了SPTRF蛋白在紫色海胆的先天免疫系统中的多方面和动态功能。它们的功能多样化，可以实现强大的免疫反应，同时还提供了一种独特的调节机制，通过控制响应水平并将其调整为外国威胁水平。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39936151/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39936151</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810900/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810900</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1496832>10.3389/fimmu.2024.1496832</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39936151</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator>莱利的乌鸦</dc:creator><dc:creator>莱昂·格雷弗（Leon Grayfer）</dc:creator><dc:creator> l考特尼·史密斯</dc:creator><dc:date>2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>重组Sptransformer蛋白与海胆吞噬细胞上的特定位点结合并调节&lt;em>; sptransformer &lt;/em>;基因表达和免疫反应性</dc:title><dc:identifier>PMID：39936151</dc:identifier><dc:identifier> PMC：PMC11810900</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1496832</dc:identifier></item><item><title>为什么很难理解为什么我们不了解人类的系统性红斑狼疮？考虑“因果关系级联范式”的事实，冲突和影响</title><link/>https://pubmed.ncbi.nlm.nih.gov/39936150/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign = journals&amp;utm_contm_content = 101560960＆fc = none＆fc = nOone&amp;ff=202502102502101250210250210210250210210250210210210125021021021021025022022025022025021025021022022025022022022022025022025转<description>为了理解系统性红斑狼疮（SLE），我们发现自己处于智力，以致病性为导向的科学，哲学，经验主义和合格的猜想之间的智力交叉点。科学理论中的一个至关重要的后果是，未经严格研究的科学假设有被转化为科学教条的危险。该陈述对这项研究产生了影响。 Two central problematic aspects are discussed.首先，我们必须... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月28日； 15：1507792。 doi：10.3389/fimmu.2024.1507792。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">为了理解系统性红斑狼疮（SLE），我们发现自己处于智力，以致病性为导向的科学，哲学，经验主义和合格的猜想之间的智力交叉点。科学理论中的一个至关重要的后果是，未经严格研究的科学假设有被转化为科学教条的危险。该陈述对这项研究产生了影响。讨论了两个中心问题。首先，我们必须考虑因果关系原则的分类标准整合的新选择原则。其次，如果我们要了解SLE，则必须实施中央历史数据。这些数据包括与遗传机械相关的不同，动态变化的DNA结构的著名描述。这些独特的结构自从几十年前的发现以来，大多数人在SLE研究中都被忽略了。同样，不确定的教条数据表明，不同的肾小球配体是通过肾脏生成抗DSDNA抗体暴露的染色质片段或固有的膜配体识别的。这些不一致的模型尚未进行相对和系统地研究。将对三个研究领域进行严格讨论：（ <i>i</i> ）SLE分类标准的选择和作用，这一过程必须暗示因果关系原则； （ <i>ii</i> ）抗DSDNA结构特异性抗体的定义和影响； （ <i>iii</i> ）解释狼疮性肾炎的不一致的致病模型。一个精确且至关重要的问题是，SLE本身是否是对启动一系列下游效应（标准）或SLE是否代表对多个原因效应事件的随机相互作用的组合响应的主要统一原因的反应。这些主要不同的解释如今未正式排除或接受。当前，SLE可以被视为具有表型多样性的疾病，独立隔离的表现形式具有未解决的病因，而这种疾病并非单一SLE表型所独有。本讨论的重点基本上是我们通过关键假设如何重新考虑基于科学的SLE分类标准的选择，以将SLE界定和合理化。在本讨论中，分类标准，自身免疫性，DNA结构和抗DSDNA抗体是综合方面。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39936150/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39936150</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11811100/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11811100</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1507792>10.3389/fimmu.2024.1507792</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39936150</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Ole Petter Rekvig</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>为什么很难理解为什么我们不了解人类的系统性红斑狼疮？考虑“因果关系级联范式”的事实，冲突和影响</dc:title><dc:identifier>PMID：39936150</dc:identifier><dc:identifier> PMC：PMC11811100</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1507792</dc:identifier></item><item><title>白介素-1信号传导和CD4 &lt;sup>;+&lt;/sup>; T细胞控制B细胞募集到慢性铍病中的肺</title><link/>https://pubmed.ncbi.nlm.nih.gov/39935485/？<description>慢性铍病（CBD）是一种使人衰弱的肺部疾病，由于工作场所中持续暴露于铍（BE）颗粒而发生。暴露会导致先天免疫系统的激活，从而导致白细胞室和趋化因子的分泌，从而驱动B和T细胞在肺部的积累。然而，对CBD中B细胞募集和B细胞介导的保护的募集的机制知之甚少。在这项研究中，我们... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月28日； 16：1479348。 doi：10.3389/fimmu.2025.1479348。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">慢性铍病（CBD）是一种使人衰弱的肺部疾病，由于工作场所中持续暴露于铍（BE）颗粒而发生。暴露会导致先天免疫系统的激活，从而导致白细胞室和趋化因子的分泌，从而驱动B和T细胞在肺部的积累。然而，对CBD中B细胞募集和B细胞介导的保护的募集的机制知之甚少。在这项研究中，我们采用了多种方法来检查先天免疫信号传导和CD4 <sup>+</sup> T细胞在肺中B细胞募集和功能中的作用。我们表明，IL-1R1信号的缺失或阻塞阻止了B细胞募集到暴露于Beo暴露的小鼠的肺部。此外，我们表明对肺的B细胞募集取决于趋化因子受体，CXCR5和CD4 <sup>+</sup> T细胞。 In BeO-exposed mice, lung B cells down-regulate IgM but showed an increased IgD and CD44 surface expression.此外，CBD中肺组织特异性B细胞的RNA测序与脾B细胞相比揭示了独特的基因特征，并且涉及抗原表现，紧密连接相互作用和干扰素信号的途径的表达增加。总体而言，我们的研究表明，在CBD期间，B细胞募集和骨料形成取决于先天和适应性免疫反应的顺序激活。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39935485/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39935485</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810750/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810750</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1479348>10.3389/fimmu.2025.1479348</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39935485</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator>约瑟夫·M·加巴拉（Joseph M Gaballa）</dc:creator><dc:creator>卡利·瓦尔迪兹（Caley Valdez）</dc:creator><dc:creator>道格拉斯·麦克（Douglas G Mack）</dc:creator><dc:creator> Faiz Minhajuddin</dc:creator><dc:creator> Masoom Raza</dc:creator><dc:creator>塔布雷斯·穆罕默德</dc:creator><dc:creator>艾莉森·马丁（Allison K Martin）</dc:creator><dc:creator>安德鲁·盖特亨（Andrew Getahun）</dc:creator><dc:creator>查尔斯·迪纳雷洛（Charles a Dinarello）</dc:creator><dc:creator>安德鲁·富特诺特（Andrew P Fontenot）</dc:creator><dc:creator> Shaikh M Atif</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>白介素-1信号传导和CD4 &lt;sup>;+&lt;/sup>; T细胞控制B细胞募集到慢性铍病中的肺</dc:title><dc:identifier>PMID：39935485</dc:identifier><dc:identifier> PMC：PMC11810750</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1479348</dc:identifier></item><item><title>案例报告：小儿难治性狼疮肾炎中的抗CD20和抗CD38单克隆抗体的单一输注</title><link/>https://pubmed.ncbi.nlm.nih.gov/39935484/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250212091005&amp;v=2.18.0.post9+e462414<description>狼疮肾炎（LN），有30％-50％的全身性红斑狼疮（SLE）患者，通常需要标准的免疫抑制治疗（葡萄糖皮质激素，MMF，CYC），这是欧洲反对逆变化的肾脏和欧洲肾脏 - 肾脏 - 伊鲁群岛 - 伊鲁群岛 - 伊鲁群岛 - 伊鲁群岛 - 肾上腺素 -  Europeans-euurepaniass-euurepans-euurepis-diallysis-移植协会（Eular/ERA-EDTA）和肾脏疾病改善了全球结果（KDIGO）指南。但是，受试者的一部分仍然是难治性的。最近的发现表明，靶向CD38长的... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月28日； 16：1525892。 doi：10.3389/fimmu.2025.1525892。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">狼疮肾炎（LN），有30％-50％的全身性红斑狼疮（SLE）患者，通常需要标准的免疫抑制治疗（葡萄糖皮质激素，MMF，CYC），这是欧洲反对逆变化的肾脏和欧洲肾脏 - 肾脏 - 伊鲁群岛 - 伊鲁群岛 - 伊鲁群岛 - 伊鲁群岛 - 肾上腺素 -  Europeans-euurepaniass-euurepans-euurepis-diallysis-移植协会（Eular/ERA-EDTA）和肾脏疾病改善了全球结果（KDIGO）指南。但是，受试者的一部分仍然是难治性的。最近的发现表明，靶向LN和SLE难治性CD38长的浆细胞对标准处理的疗效。但是，以前的经验仅限于成年患者，并描述了基于d​​aratumumab的不同治疗方案，并增加了贝尔木单抗。 Moreover, the minimal effective dose of daratumumab has yet to be fully defined.在本报告中，我们描述了两例少年性耐火LN/SLE成功通过单个输注利妥昔单抗（靶向B细胞靶向CD20）和daratumumab（靶向持久的浆细胞靶向CD38），成功地管理了两种情况需要长时间的daratumab输注。我们的方法是安全有效的，可能有可能降低不良影响和成本，为少年难治性LN提供了一种新颖的治疗选择。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39935484/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39935484</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810895/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810895</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1525892>10.3389/fimmu.2025.1525892</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39935484</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Decimo Silvio Chiarenza</dc:creator><dc:creator>劳尔·曼奇尼（Raul Mancini）</dc:creator><dc:creator>卡罗来纳州Bigatti</dc:creator><dc:creator> Gianluca Caridi</dc:creator><dc:creator>亚历山德罗·康洛洛（Alessandro Consolaro）</dc:creator><dc:creator>瓦伦蒂娜·纳托利（Valentina Natoli）</dc:creator><dc:creator> Gabriele Mortari</dc:creator><dc:creator> Xhuliana Kajana</dc:creator><dc:creator>弗朗西斯卡·卢加尼（Francesca Lugani）</dc:creator><dc:creator> Marco Gattorno</dc:creator><dc:creator> Gian Marco Ghiggeri</dc:creator><dc:creator> Edoardo La Porta</dc:creator><dc:creator> Gabriele Gagerso</dc:creator><dc:creator> Enrico E Verrina</dc:creator><dc:creator>安德里亚·安吉莱蒂（Andrea Angeletti）</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>案例报告：小儿难治性狼疮肾炎中的抗CD20和抗CD38单克隆抗体的单一输注</dc:title><dc:identifier>PMID：39935484</dc:identifier><dc:identifier> PMC：PMC11810895</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1525892</dc:identifier></item><item><title>病例报告：在患有施尼兹勒综合征患者的硼替佐米的治疗用途</title><link/>https://pubmed.ncbi.nlm.nih.gov/39935483/？<description> Schnitzler综合征（SCHS）是一种罕见的获得的全身自身炎症疾病，其特征是慢性荨麻疹皮疹和免疫球蛋白M（IGM）单克隆性麻痹。与抗IL-6疗法相比，已经证明抗Interleukin-1（IL-1）疗法在管理SCHS的临床症状方面更有效。在本案报告中，我们向一名男性患者出现荨麻疹，发烧和关节痛。实验室测试确定了IGMκ单克隆蛋白的存在，并且没有... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月28日； 16：1520470。 doi：10.3389/fimmu.2025.1520470。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Schnitzler综合征（SCHS）是一种罕见的获得的全身自身炎症疾病，其特征是慢性荨麻疹皮疹和免疫球蛋白M（IGM）单克隆性麻痹。与抗IL-6疗法相比，已经证明抗Interleukin-1（IL-1）疗法在管理SCHS的临床症状方面更有效。在这种情况下，我们向一名男性患者提出了荨麻疹，发烧和关节痛。实验室测试确定了IGMκ单克隆蛋白的存在，以及在血清中不存在IL-1β。整个外显子组测序（WES）没有揭示与单基因自炎性疾病或<i>MYD88</i> L265p突变有关的任何病理变异。他符合SCHS的诊断标准，并接受了硼替佐米治疗，从而显着改善临床症状和IGMκ单克隆蛋白水平的下降。患者可以很好地容忍治疗。该病例表明，除了抗IL-1疗法和布鲁顿酪氨酸激酶（BTK）抑制剂外，硼替佐米可以被视为SCHS的潜在治疗选择。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39935483/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39935483</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810973/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810973</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1520470>10.3389/fimmu.2025.1520470</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39935483</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Hua Bai</dc:creator><dc:creator> Dongming Zhou</dc:creator><dc:creator> Jinwen Liu</dc:creator><dc:creator> Jie He</dc:creator><dc:creator>周敏</dc:creator><dc:creator>Wenyong粉丝</dc:creator><dc:creator>Bing Chen</dc:creator><dc:creator>杨Xu</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>病例报告：在患有施尼兹勒综合征患者的硼替佐米的治疗用途</dc:title><dc:identifier>PMID：39935483</dc:identifier><dc:identifier> PMC：PMC11810973</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1520470</dc:identifier></item><item><title>年龄影响小儿败血症的循环免疫特征</title><link/>https://pubmed.ncbi.nlm.nih.gov/39935482/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250212091005&amp;v=2.18.0.post9+e462414<description>结论：调节性T细胞衰竭可能导致小儿脓毒症的发病机理。年龄是影响败血症相关的免疫失调和周围循环中的记忆T细胞的重要变量，仅败血症与年龄相关。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月28日； 16：1527142。 doi：10.3389/fimmu.2025.1527142。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：随着患者的年龄，免疫反应的变化，但是对败血症的免疫失调的研究通常不会将年龄视为关键变量。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：我们假设年龄会影响化脓性儿童的免疫反应，并且健康儿童和患有败血症，不复杂感染或急性器官功能障碍的健康儿童和儿童免疫特征的不同。我们表征了向我们的三级护理儿童医院出示的儿童的循环免疫力。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：这项调查是一项前瞻性的，观察性的研究，该研究从2020年7月至2022年9月开始招募患者。如果患者小于21岁，被PICU录取并接受了液体复苏和抗生素。从PICU第1天收集的样品中分离出外周血单核细胞。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：八十名患者被招募。患有败血症的儿童具有更多的调节性CD4 <sup>+</sup> T细胞和记忆CD4 <sup>+</sup> T细胞，CD4 <sup>+</sup> IL-10 <sup>+</sup>和CD8 <sup>+</sup> T-bet <sup>+</sup> T细胞的含量较少。<i>离体</i>刺激后，败血症样品的CD4 <sup>+</sup> T细胞降低了IL-10的降低，而不是健康对照。记忆CD4 <sup>+</sup> T细胞和调节性CD4 <sup>+</sup> T细胞仅在败血症中与年龄呈正相关。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：调节性T细胞衰竭可能导致小儿脓毒症的发病机理。年龄是影响败血症相关的免疫失调和周围循环中的记忆T细胞的重要变量，仅败血症与年龄相关。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39935482/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39935482</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810941/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810941</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1527142>10.3389/fimmu.2025.1527142</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39935482</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator>格蕾丝·菲斯勒（Grace Fisler）</dc:creator><dc:creator> Mariana R Brewer</dc:creator><dc:creator>奥马尔·亚彭（Omar Yaipen）</dc:creator><dc:creator>克利福德（Clifford）的德意志人</dc:creator><dc:creator>马修·泰勒（Matthew D Taylor）</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>年龄影响小儿败血症的循环免疫特征</dc:title><dc:identifier>PMID：39935482</dc:identifier><dc:identifier> PMC：PMC11810941</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1527142</dc:identifier></item><item><title> IL-33信号传导对于IL-10诱导的食物过敏过程中肥大细胞反应增强的增强是可分配的</title><link/>https://pubmed.ncbi.nlm.nih.gov/39935481/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250212091005&amp;v=2.18.0.post9+e462414<description>结论：我们的数据表明，IL-10可以增强WT和ST2^（ - / - ）小鼠的MC反应，进一步证实了其对MCS的促炎作用，并表明它们不受IL-33信号传导的调节。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月28日； 16：1526498。 doi：10.3389/fimmu.2025.1526498。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：IL-33/ST2轴在食物过敏过程中在IgE介导的肥大细胞（MC）反应的发展中起关键作用。我们最近证明，多效性细胞因子IL-10不仅对IgE介导的MC激活产生促炎作用，而且还促进了IL-33诱导的MC反应。但是，尚未检查IL-33对于IL-10的促炎作用是否必要。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：因此，为了确定IL-33/ST2轴在该途径中的作用，我们评估了IL-10对野生型（WT）和ST2 <sup>- / -</sup>小鼠IgE介导的MC激活和食物过敏发展的影响。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：IL-10刺激显着增强了IL-33基因表达，ST2受体表达，细胞因子产生，MMCP-1分泌以及来自WT小鼠的IgE和抗原激活的骨髓衍生的MC（BMMC）的IL-10刺激。 ST2 <sup>- / -</sup> BMMC响应IgE依赖性激活而表现出降低的细胞因子分泌。但是，IL-10也增强了这些细胞中细胞因子的产生，MMCP-1分泌和增殖。为了进一步评估IL-10的作用，在WT和ST2 <sup>- / -</sup>小鼠中诱导食物过敏，受到抗体介导的IL-10耗竭。 IL-10耗尽的WT小鼠在MC介导的OVA挑战的反应中表现出明显的衰减。 While ST2 <sup>-/-</sup> mice also exhibited a profound suppression of MC responses, IL-10 depletion had no additional effects.但是，与ST2 <sup>- / -</sup>小鼠相比，ST2 <sup>- / -</sup> /IL-10 <sup>- / -</sup>小鼠在OVA-Ige和抗原特异性MC激活中表现出进一步降低。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的数据表明，IL-10可以增强WT和ST2 <sup>- / -</sup>小鼠的MC响应，进一步证实了其对MC的促炎作用，并表明它们不受IL-33信号传导的调节。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39935481/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39935481</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810977/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810977</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1526498>10.3389/fimmu.2025.1526498</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39935481</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Dylan Krajewski</dc:creator><dc:creator> Saurav Ranjitkar</dc:creator><dc:creator>内森·乔丹（Nathan Jordan）</dc:creator><dc:creator> Sallie S Schneider</dc:creator><dc:creator>克林顿B马西亚斯</dc:creator><dc:date>2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>IL-33信号传导对于IL-10诱导的食物过敏过程中肥大细胞反应增强的增强是可分配的</dc:title><dc:identifier>PMID：39935481</dc:identifier><dc:identifier> PMC：PMC11810977</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1526498</dc:identifier></item><item><title> &lt;em>;In silico&lt;/em>; design of a multi-epitope vaccine against &lt;em>;Mycobacterium avium&lt;/em>; subspecies &lt;em>;paratuberculosis&lt;/em>;</title><link/> https://pubmed.ncbi.nlm.nih.gov/39935480/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250212091005&amp;v=2.18.0.post9+e462414<description> The widespread chronic enteritis known as Paratuberculosis (PTB) or Johne&#39;s disease (JD) is caused by Mycobacterium avium subspecies paratuberculosis (MAP), posing a significant threat to global public health. Given the challenges associated with PTB or JD, the development and application of vaccines are potentially important for disease control. The aim of this study was to design a multi-epitope vaccine against MAP. A total of 198 MAP genomes were analyzed using pan-genome and reverse... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Jan 28;16:1505313. doi: 10.3389/fimmu.2025.1505313.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> The widespread chronic enteritis known as Paratuberculosis (PTB) or Johne&#39;s disease (JD) is caused by <i>Mycobacterium avium</i> subspecies <i>paratuberculosis</i> (MAP), posing a significant threat to global public health. Given the challenges associated with PTB or JD, the development and application of vaccines are potentially important for disease control. The aim of this study was to design a multi-epitope vaccine against MAP. A total of 198 MAP genomes were analyzed using pan-genome and reverse vaccinology approaches. B-cell and T-cell epitope analysis was performed on the selected promising cross-protective antigens followed by selection of epitopes with high antigenicity, no allergenicity, and no toxicity for the design of the vaccine. The designed vaccine was evaluated through molecular dynamics simulations, molecular docking, and immunological simulations. The results revealed the identification of five promising cross-protective antigens. In total, 10 B-cell epitopes, 10 HTL epitopes, and 9 CTL epitopes were selected for the design of the vaccine. Both the vaccine candidate and the vaccine-TLR4 complex demonstrated considerable stability in molecular dynamics simulations. Molecular docking studies confirmed that the vaccine candidate successfully interacted with TLR4. Immunological simulations showed an increase in both B-cell and T-cell populations after vaccination. Additionally, the vaccine candidate exhibited a codon adaptability index of 1.0 and a GC content of 53.64%, indicating strong potential for successful expression in <i>Escherichia coli</i> . This research developed a multi-epitope vaccine targeting MAP through pan-genomes and reverse vaccinology methods, offering innovative strategies for creating effective vaccines against MAP.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39935480/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39935480</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810964/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810964</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1505313>10.3389/fimmu.2025.1505313</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39935480</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Weiqi Guo</dc:creator><dc:creator> Xinyu Wang</dc:creator><dc:creator> Jiangang Hu</dc:creator><dc:creator> Beibei Zhang</dc:creator><dc:creator> Luru Zhao</dc:creator><dc:creator> Guangdong Zhang</dc:creator><dc:creator> Jingjing Qi</dc:creator><dc:creator> Zuzhang Wei</dc:creator><dc:creator> Yanqing Bao</dc:creator><dc:creator> Mingxing Tian</dc:creator><dc:creator> Shaohui Wang</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>&lt;em>;In silico&lt;/em>; design of a multi-epitope vaccine against &lt;em>;Mycobacterium avium&lt;/em>; subspecies &lt;em>;paratuberculosis&lt;/em>;</dc:title><dc:identifier> pmid:39935480</dc:identifier><dc:identifier> pmc:PMC11810964</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1505313</dc:identifier></item><item><title> Castleman disease misdiagnosed as immunoglobulin G4-related disease: a case report</title><link/> https://pubmed.ncbi.nlm.nih.gov/39935479/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250212091005&amp;v=2.18.0.post9+e462414<description> Castleman disease (CD) and immunoglobulin G4-related disease (IgG4-RD) are rare systemic immune-mediated disorders that share overlapping clinical features, posing significant challenges in differential diagnosis. Here, we present a case of generalized lymphadenopathy initially misdiagnosed as IgG4-RD, which demonstrated a poor response to hormonal therapy. Subsequent pathological biopsy and immunohistochemical analysis ultimately confirmed the diagnosis of CD. This case underscores the... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Jan 28;16:1532627. doi: 10.3389/fimmu.2025.1532627.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Castleman disease (CD) and immunoglobulin G4-related disease (IgG4-RD) are rare systemic immune-mediated disorders that share overlapping clinical features, posing significant challenges in differential diagnosis. Here, we present a case of generalized lymphadenopathy initially misdiagnosed as IgG4-RD, which demonstrated a poor response to hormonal therapy. Subsequent pathological biopsy and immunohistochemical analysis ultimately confirmed the diagnosis of CD. This case underscores the limitations of relying solely on serum IgG4 levels as a diagnostic marker to distinguish CD from IgG4-RD. Comprehensive evaluation, including clinical presentation, organ involvement, serological and pathological findings, as well as therapeutic response, is essential to ensure accurate diagnosis and timely management.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39935479/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39935479</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810934/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810934</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1532627>10.3389/fimmu.2025.1532627</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39935479</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Na Li</dc:creator><dc:creator> LiFen Xu</dc:creator><dc:creator> Xiaoxia Liu</dc:creator><dc:creator> Pengjia Wu</dc:creator><dc:creator> Jun Liu</dc:creator><dc:creator> Jiashun Zeng</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>Castleman disease misdiagnosed as immunoglobulin G4-related disease: a case report</dc:title><dc:identifier> pmid:39935479</dc:identifier><dc:identifier> pmc:PMC11810934</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1532627</dc:identifier></item><item><title> Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O)</title><link/> https://pubmed.ncbi.nlm.nih.gov/39935478/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250212091005&amp;v=2.18.0.post9+e462414<description> In this article we discuss characteristics of fusion protein-based SARS-CoV-2 vaccines. We focus on recombinant vaccine antigens comprising fusion proteins consisting of combinations of SARS-CoV-2-derived antigens or peptides or combinations of SARS-CoV-2 antigens/peptides with SARS-CoV-2-unrelated proteins/peptides. These fusion proteins are made to increase the immunogenicity of the vaccine antigens and/or to enable special targeting of the immune system. The protein-based vaccine approach is... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Jan 28;16:1452814. doi: 10.3389/fimmu.2025.1452814.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> In this article we discuss characteristics of fusion protein-based SARS-CoV-2 vaccines. We focus on recombinant vaccine antigens comprising fusion proteins consisting of combinations of SARS-CoV-2-derived antigens or peptides or combinations of SARS-CoV-2 antigens/peptides with SARS-CoV-2-unrelated proteins/peptides. These fusion proteins are made to increase the immunogenicity of the vaccine antigens and/or to enable special targeting of the immune system. The protein-based vaccine approach is exemplified solely in a proof of concept study by using W-PreS-O, a chimeric vaccine based on a single fusion protein (W-PreS-O), combining RBDs from Wuhan hu-1 wild-type and Omicron BA.1 with the hepatitis B virus (HBV)-derived PreS surface antigen adsorbed to aluminum hydroxide. The W-PreS-O vaccine was evaluated in Syrian hamsters which were immunized three times at three-week intervals with W-PreS-O or with aluminum hydroxide (placebo) before they were infected with Omicron BA.1. Neutralizing antibody (nAB) titers, weight, lung symptoms, and viral loads, as measured using RT-PCR in the upper and lower respiratory tracts, were determined. In addition, infectious virus titers from the lungs were measured using a plaque-forming assay. We found that W-PreS-O-vaccinated hamsters developed robust nABs against Omicron BA.1, showed almost no development of pneumonia, and had significantly reduced infectious virus titers in the lungs. Importantly, the viral loads in the nasal cavities of W-PreS-O-vaccinated hamsters were close to or above the PCR cycle threshold considered to be non-infectious. The data of our proof-of-concept study provides compelling evidence that the W-PreS-O vaccine has protective effect against Omicron BA.1 in a Syrian hamster <i>in vivo</i> infection model and thus support the promising results obtained also for other fusion protein-based SARS-CoV-2 vaccines.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39935478/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39935478</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11811753/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11811753</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1452814>10.3389/fimmu.2025.1452814</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39935478</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Pia Gattinger</dc:creator><dc:creator> Luibov I Kozlovskaya</dc:creator><dc:creator> Alexander S Lunin</dc:creator><dc:creator> Olga S Gancharova</dc:creator><dc:creator> Dina I Sirazova</dc:creator><dc:creator> Vasiliy D Apolokhov</dc:creator><dc:creator> Egor S Chekina</dc:creator><dc:creator> Ilya V Gordeychuk</dc:creator><dc:creator> Alexander V Karaulov</dc:creator><dc:creator> Rudolf Valenta</dc:creator><dc:creator> Aydar A Ishmukhametov</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O)</dc:title><dc:identifier> pmid:39935478</dc:identifier><dc:identifier> pmc:PMC11811753</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1452814</dc:identifier></item><item><title> Definition of clinical immunology around the globe</title><link/> https://pubmed.ncbi.nlm.nih.gov/39935477/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250212091005&amp;v=2.18.0.post9+e462414<description> Immunology has gradually become a core part of many medical specialties. Immune cells and immune mediators are now known to participate in the pathogenesis of a wide variety of diseases and therapies based on the modulation of immune function are increasingly used. Traditionally, clinical immunologists have studied patients with inborn errors of immunity (IEI), previously known as primary immunodeficiencies, and with allergic conditions. More recently, clinical immunology has become involved... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Jan 28;16:1483391. doi: 10.3389/fimmu.2025.1483391.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Immunology has gradually become a core part of many medical specialties. Immune cells and immune mediators are now known to participate in the pathogenesis of a wide variety of diseases and therapies based on the modulation of immune function are increasingly used. Traditionally, clinical immunologists have studied patients with inborn errors of immunity (IEI), previously known as primary immunodeficiencies, and with allergic conditions. More recently, clinical immunology has become involved with a broader array of disorders. The Clinical Immunology Committee of the International Union of Immunological Societies set out to understand how clinical immunologists perceive their specialty to identify similarities and differences in training and practice around the globe. For this purpose, a specific questionnaire was designed and distributed amongst our member societies. More than 500 participants answered the questionnaire, 80% of whom had completed their training. Roughly two thirds of respondents were physicians directly involved in patient care. We found that though the number of diseases and processes in which immune mechanisms are involved has considerably grown, 90% of participants agree with the 1993 World Health Organization definition of Clinical Immunology. We propose that the increased complexity of the field opens a need for multidisciplinary teams of clinicians and basic researchers and for a broader training of specialists.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39935477/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">39935477</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11810920/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250212091005&v=2.18.0.post9+e462414">PMC11810920</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1483391>10.3389/fimmu.2025.1483391</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39935477</guid><pubDate> Wed, 12 Feb 2025 06:00:00 -0500</pubDate><dc:creator> José C Crispín</dc:creator><dc:creator> Tineke Cantaert</dc:creator><dc:creator> Alberto Pinzon-Charry</dc:creator><dc:creator> Domenico Mavilio</dc:creator><dc:creator> Ahmed Seri</dc:creator><dc:creator> Pierre Miossec</dc:creator><dc:date> 2025-02-12</dc:date><dc:source>免疫学领域</dc:source><dc:title>Definition of clinical immunology around the globe</dc:title><dc:identifier> pmid:39935477</dc:identifier><dc:identifier> pmc:PMC11810920</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1483391</dc:identifier></item></channel></rss>